Rituxumab Combined With Chemotherapy (PVB [prednisolone, vincristine, and bleomycin]) For Poor Prognosis HIV-Related Non-Hodgkin's Lymphoma.

Trial Profile

Rituxumab Combined With Chemotherapy (PVB [prednisolone, vincristine, and bleomycin]) For Poor Prognosis HIV-Related Non-Hodgkin's Lymphoma.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 05 May 2009

At a glance

  • Drugs Rituximab (Primary) ; Bleomycin; Prednisolone; Vincristine
  • Indications Non-Hodgkin's lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top